-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical has been awarded the title of “Contract-Abiding and Creditworthy Enterprise of Shijiazhuang City.”
Category:
Time：2023-06-16
Recently, good news came from the Shijiazhuang Municipal Administration for Market Regulation: Shijiazhuang Sihua Pharmaceutical Co., Ltd. has been recognized as a “Shijiazhuang City Contract-Abiding and Creditworthy Enterprise for 2021-2022” thanks to its sound corporate credit management system and excellent contract performance and credit standing.
Recently, good news came from the Shijiazhuang Municipal Administration for Market Regulation: Shijiazhuang Sihua Pharmaceutical Co., Ltd. has been recognized as a “Contract-Abiding and Creditworthy Enterprise of Shijiazhuang City for the 2021-2022 Period” thanks to its sound corporate credit management system and excellent contract performance and credit standing.
It is reported that the “Shijiazhuang City Contract-Abiding and Creditworthy Enterprise” selection activity is organized and conducted by the Shijiazhuang Municipal Administration for Market Regulation. The initiative aims to promote corporate credit building, enhance enterprises’ brand image, and provide them with strong qualification resources to help them gain a competitive edge in the market.
As a key backbone enterprise in Shijiazhuang’s biopharmaceutical industry, Shijiazhuang Fourth Pharmaceutical operates on the principle of integrity and has established “integrity-based” as its corporate ethos. It regards integrity as a vital soft power for business operations and development, continuously strengthening contract management, solidifying its credit foundation, fostering a corporate culture of integrity, building an integrity-driven brand, and elevating the level of integrity-building within the company. The company actively puts into practice the principles of “integrity-driven management” and “honest fulfillment of contracts” across all aspects of its business operations.
The successful development of sound corporate credit has enabled the company to become a leader in high-quality industry development, earning widespread acclaim and respect from both the market and society. The company has successively earned prestigious honors such as “National Model Enterprise for Contract Compliance and Creditworthiness,” “Hebei Provincial Government Quality Award,” “China’s AAA Credit-rated Enterprise,” and “Hebei Province Integrity Enterprise.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license